Jeffrey R. Colin
Greenberg Traurig, LLP
Jeffrey R. Colin concentrates his practice on complex patent litigation with a focus on pharmaceuticals, chemicals, biotechnology, biologics, medical devices, and consumer electronics. Jeffrey has experience litigating patent infringement cases arising under the Hatch-Waxman Act and pertaining to drugs for treating various diseases including benign prostatic hyperplasia, migraines, high triglycerides, acne, cold/flu, attention deficit hyperactivity disorder, irritable bowel syndrome, and hepatic encephalopathy, as well as cases concerning cellular technology and software.
Jeffrey has participated in all stages of litigation from pre-suit through appeal. Jeffrey has also provided general intellectual property counseling to clients, conducted due diligence analyses, and drafted freedom to operate opinions.